The latest price target for Vericel (NASDAQ:VCEL) was reported by Truist Securities on March 3, 2025. The analyst firm set a price target for $61.00 expecting VCEL to rise to within 12 months (a possible 43.94% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Vericel (NASDAQ:VCEL) was provided by Truist Securities, and Vericel reiterated their buy rating.

The last upgrade for Vericel Corp happened on January 25, 2024 when Truist Securities raised their price target to $51. Truist Securities previously had a hold for Vericel Corp.

The last downgrade for Vericel Corp happened on November 10, 2022 when BTIG changed their price target from N/A to N/A for Vericel Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vericel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vericel was filed on March 3, 2025 so you should expect the next rating to be made available sometime around March 3, 2026.

While ratings are subjective and will change, the latest Vericel (VCEL) rating was a reiterated with a price target of $67.00 to $61.00. The current price Vericel (VCEL) is trading at is $42.38, which is out of the analyst’s predicted range.